OneMedNet (ONMD) Net Income towards Common Stockholders (2021 - 2026)

OneMedNet (ONMD) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$2.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 178.78% year-over-year to -$2.2 million in Q2 2026; TTM through Jun 2026 was -$8.6 million, a 99.23% decrease from a year earlier, with the FY2025 full-year figure at -$2.2 million, up 77.82% from the prior year.
• Net Income towards Common Stockholders was -$2.2 million for Q2 2026 at OneMedNet, up from -$2.6 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $2.8 million in Q2 2025 and troughed at -$49.3 million in Q4 2022.
• A 5-year average of -$5.5 million and a median of -$2.1 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders jumped 130011.72% in 2022 and plunged 69481.23% in 2024, its largest moves.
• Over 5 years, Net Income towards Common Stockholders stood at -$49.3 million in 2022, then surged by 33.26% to -$32.9 million in 2023, then surged by 91.67% to -$2.7 million in 2024, then slipped by 12.65% to -$3.1 million in 2025, then increased by 29.71% to -$2.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.2 million (Q2 2026), -$2.6 million (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.